Soiken Holdings Inc. (TYO:2385)
Japan · Delayed Price · Currency is JPY 251.00
+2.00 (0.80%)
Apr 17, 2026, 3:30 PM JST
Soiken Holdings Revenue
Soiken Holdings had revenue of 999.00M JPY in the quarter ending December 31, 2025, a decrease of -22.62%. This brings the company's revenue in the last twelve months to 4.58B, down -8.44% year-over-year. In the fiscal year ending June 30, 2025, Soiken Holdings had annual revenue of 4.85B, down -6.01%.
Revenue (ttm)
4.58B
Revenue Growth
-8.44%
P/S Ratio
1.43
Revenue / Employee
93.45M
Employees
49
Market Cap
6.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 4.85B | -310.00M | -6.01% |
| Jun 30, 2024 | 5.16B | -2.92B | -36.16% |
| Jun 30, 2023 | 8.08B | -1.27B | -13.57% |
| Jun 30, 2022 | 9.35B | 405.00M | 4.53% |
| Jun 30, 2021 | 8.94B | -370.00M | -3.97% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Linical | 9.32B |
| Kohjin Bio | 5.07B |
| CellSource | 3.72B |
| StemCell Institute | 2.78B |
| MEDINET | 998.00M |
| PRISM BioLab Co.,LTD | 684.61M |
| Chiome Bioscience | 593.29M |
| Carna Biosciences | 579.00M |